Komplementsystem und Komplementdefekte

Tekijä Kirschfink, Michael
Julkaisussa Pädiatrie (2014)

Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention

Tekijä Fishelson, Zvi, Kirschfink, Michael
Julkaisussa Front Immunol (2019)

Modern Complement Analysis

Tekijä Kirschfink, Michael, Mollnes, Tom E.
Julkaistu 2003

Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement‐dependent anti‐tumor activity of trastuzumab and pertuzumab

Tekijä Mamidi, Srinivas, Cinci, Marc, Hasmann, Max, Fehring, Volker, Kirschfink, Michael
Julkaisussa Mol Oncol (2013)

Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection

Tekijä Protzer, Ulrike, Nassal, Michael, Chiang, Pei-Wen, Kirschfink, Michael, Schaller, Heinz
Julkaistu 1999

Interactive film scenes for tutor training in problem-based learning (PBL): dealing with difficult situations

Tekijä Bosse, Hans M, Huwendiek, Soeren, Skelin, Silvia, Kirschfink, Michael, Nikendei, Christoph
Julkaistu 2010

Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells

Tekijä Mamidi, Srinivas, Höne, Simon, Teufel, Claudia, Sellner, Leopold, Zenz, Thorsten, Kirschfink, Michael
Julkaisussa Oncoimmunology (2015)

Increased compensatory kidney workload results in cellular damage in a short time porcine model of mixed acidemia – Is acidemia a ‘first hit’ in acute kidney injury?

Tekijä Russ, Martin, Ott, Sascha, Bedarf, Janis R., Kirschfink, Michael, Hiebl, Bernhard, Unger, Juliane K.
Julkaisussa PLoS One (2019)

Developing medical educators – a mixed method evaluation of a teaching education program

Tekijä Roos, Marco, Kadmon, Martina, Kirschfink, Michael, Koch, Eginhard, Jünger, Jana, Strittmatter-Haubold, Veronika, Steiner, Thorsten
Julkaistu 2014

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies

Tekijä Münch, Johannes, Bachmann, Anette, Grohmann, Maik, Mayer, Christof, Kirschfink, Michael, Lindner, Tom H, Bergmann, Carsten, Halbritter, Jan
Julkaisussa Clin Kidney J (2017)

Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome: A Case Report

Tekijä Kronbichler, Andreas, Frank, Renate, Kirschfink, Michael, Szilágyi, Ágnes, Csuka, Dorottya, Prohászka, Zoltán, Schratzberger, Peter, Lhotta, Karl, Mayer, Gert
Julkaisussa Medicine (Baltimore) (2014)

Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome

Tekijä Mache, Christoph J., Acham-Roschitz, Birgit, Frémeaux-Bacchi, Veronique, Kirschfink, Michael, Zipfel, Peter F., Roedl, Siegfried, Vester, Udo, Ring, Ekkehard
Julkaistu 2009

Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties

Tekijä Röttgerding, Florian, Wagemakers, Alex, Koetsveld, Joris, Fingerle, Volker, Kirschfink, Michael, Hovius, Joppe W., Zipfel, Peter F., Wallich, Reinhard, Kraiczy, Peter
Julkaisussa Sci Rep (2017)

Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis

Tekijä Chanchlani, Rahul, Thorner, Paul, Radhakrishnan, Seetha, Hebert, Diane, Langlois, Valerie, Arora, Steven, Barth, David, Cattran, Daniel, Kirschfink, Michael, Licht, Christoph
Julkaisussa Kidney Int Rep (2017)

Author Correction: Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties

Tekijä Röttgerding, Florian, Wagemakers, Alex, Koetsveld, Joris, Fingerle, Volker, Kirschfink, Michael, Hovius, Joppe W., Zipfel, Peter F., Wallich, Reinhard, Kraiczy, Peter
Julkaisussa Sci Rep (2019)

A novel multiplex detection array revealed systemic complement activation in oral squamous cell carcinoma

Tekijä Gallenkamp, Juliane, Spanier, Gerrit, Wörle, Elisabeth, Englbrecht, Markus, Kirschfink, Michael, Greslechner, Roman, Braun, Regine, Schäfer, Nicole, Bauer, Richard J., Pauly, Diana
Julkaisussa Oncotarget (2017)

Immunological Alterations due to Hemodialysis Might Interfere with Early Complications in Renal Transplantation

Tekijä Mai, Kristin, Boldt, Andreas, Hau, Hans-Michael, Kirschfink, Michael, Schiekofer, Stephan, Keller, Frieder, Beige, Joachim, Giannis, Athanassios, Sack, Ulrich, Rasche, Franz Maximilian
Julkaisussa Anal Cell Pathol (Amst) (2019)

European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guide...

Tekijä Brodszki, Nicholas, Frazer-Abel, Ashley, Grumach, Anete S., Kirschfink, Michael, Litzman, Jiri, Perez, Elena, Seppänen, Mikko R. J., Sullivan, Kathleen E., Jolles, Stephen
Julkaisussa J Clin Immunol (2020)

Identification and characterization of a unique role for EDB fibronectin in phagocytosis

Tekijä Kraft, Sabrina, Klemis, Verena, Sens, Carla, Lenhard, Thorsten, Jacobi, Christian, Samstag, Yvonne, Wabnitz, Guido, Kirschfink, Michael, Wallich, Reinhard, Hänsch, G. Maria, Nakchbandi, Inaam A.
Julkaisussa J Mol Med (Berl) (2015)

Complement factor H–related hybrid protein deregulates complement in dense deposit disease

Tekijä Chen, Qian, Wiesener, Michael, Eberhardt, Hannes U., Hartmann, Andrea, Uzonyi, Barbara, Kirschfink, Michael, Amann, Kerstin, Buettner, Maike, Goodship, Tim, Hugo, Christian, Skerka, Christine, Zipfel, Peter F.
Julkaistu 2013